April 4, 2013
Having shown steady recovery from the global economic crisis, the CEE region continues to gain investment from foreign market players, quite a few of which have already successfully established their business in the region. Local market players like
(recently acquired by the Novartis Group), have an impressively strong position within the entire CEE region, becoming a growing subject of interest for the Multinationals and their portfolio ambitions.
With this in mind,
, in partnership with
, is proud to present its inaugural conference on
Generics and Biosimilars in Central and Eastern Europe
which has been designed to
assess regulatory hurdles
share best practice
and highlight ample
We are delighted to be joined by high-quality industry professionals including
IMS Health, MHRA, Janssen Pharmaceuticals
Egis, Polpharma, Selvita
and many more. With expert speakers in generic and biosimilar development across the merging markets of CEE, this conference offers the opportunity to network and debate with leaders in this field.
Over the course of two intensive days there will be practical and informative sessions on the current and future market trends, innovation strategies in generic and biosimilar development, identifying the crucial factors in successful partnerships, commercialisation and market access. This is an essential opportunity to gather the information you need to advance your business strategy and establish yourself in this lucrative market.
For the full programme including a list of the expert speakers and to register please visit
About CPhI Conferences:
CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.